z-logo
open-access-imgOpen Access
The I Gene of Bean: A Dosage-Dependent Allele Conferring Extreme Resistance, Hypersensitive Resistance, or Spreading Vascular Necrosis in Response to the Potyvirus Bean common mosaic virus
Author(s) -
Candace Whitmer Collmer,
Marcia F. Marston,
Jane B. Taylor,
Molly M. Jahn
Publication year - 2000
Publication title -
molecular plant-microbe interactions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.565
H-Index - 153
eISSN - 1943-7706
pISSN - 0894-0282
DOI - 10.1094/mpmi.2000.13.11.1266
Subject(s) - potyvirus , biology , phaseolus , allele , potyviridae , hypersensitive response , systemic acquired resistance , plant disease resistance , cultivar , virology , immunity , virus , pathogen , genetics , gene , plant virus , immune system , botany , arabidopsis , mutant
The resistance to the potyvirus Bean common mosaic virus (BCMV) conferred by the I allele in cultivars of Phaseolus vulgaris has been characterized as dominant, and it has been associated with both immunity and a systemic vascular necrosis in infected bean plants under field, as well as controlled, conditions. In our attempts to understand more fully the nature of the interaction between bean with the I resistance allele and the pathogen BCMV, we carefully varied both I allele dosage and temperature and observed the resulting, varying resistance responses. We report here that the I allele in the bean cultivars we studied is not dominant, but rather incompletely dominant, and that the system can be manipulated to show in plants a continuum of response to BCMV that ranges from immunity or extreme resistance, to hypersensitive resistance, to systemic phloem necrosis (and subsequent plant death). We propose that the particular phenotypic outcome in bean results from a quantitative interaction between viral pathogen and plant host that can be altered to favor one or the other by manipulating I allele dosage, temperature, viral pathogen, or plant cultivar.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here